Renal SABR: Implementation of A New Standard of Care
SABR , or stereotactic ablative radiotherapie, has emerged as a new standard of care treatment option for localized renal cell carcinoma. Here, we present an accessible, high-yield guide to implementing SABR therapy for renal cell carcinoma.
Abstract (original)
SABR , or stereotactic ablative radiation therapy, has emerged as a new standard of care treatment option for localized renal cell carcinoma. Here, we present an accessible, high-yield guide to implementing SABR therapy for renal cell carcinoma. A question-and-answer format was selected for ease of navigation. Common queries around treatment indications and patient selection for SABR planning, delivery, and follow-up are addressed. Succinct, quick-hit answers are supported by relevant, contemporary literature.
Dit artikel is een samenvatting van een publicatie in Int J Radiation Oncology. Voor het volledige artikel, alle details en referenties verwijzen wij u naar de oorspronkelijke bron.
Lees het volledige artikelDOI: 10.1016/j.ijrobp.2025.12.046